Home/Filings/4/0001013606-20-000013
4//SEC Filing

Thompson Matthew 4

Accession 0001013606-20-000013

CIK 0001013606other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:04 PM ET

Size

6.4 KB

Accession

0001013606-20-000013

Insider Transaction Report

Form 4
Period: 2020-01-31
Thompson Matthew
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2020-01-31$1.00/sh783$78378,183 total
  • Award

    Common Stock

    2020-01-31+1,91478,966 total
Footnotes (2)
  • [F1]This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on February 1, 2019. 100% of the shares subject to this restricted stock unit award vested pursuant to the terms of this award.
  • [F2]Shares withheld on January 31, 2020 to satisfy statutory minimum tax withholding obligations related to shares vested on January 31, 2020.

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

Entity typeother

Related Parties

1
  • filerCIK 0001740988

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:04 PM ET
Size
6.4 KB